{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:42:16Z","timestamp":1791348136151,"version":"4.3.1"},"reference-count":33,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ejmech.2013.10.027","type":"journal-article","created":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T10:17:10Z","timestamp":1383128230000},"page":"374-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Development and biological evaluation of 99mTc-sulfonamide derivatives for in\u00a0vivo visualization of CA IX as surrogate tumor hypoxia markers"],"prefix":"10.1016","volume":"71","author":[{"given":"Vamsidhar","family":"Akurathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9593-2438","authenticated-orcid":false,"given":"Sofie","family":"Celen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja G.","family":"Lieuwes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Chitneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Cleynhens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Innocenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons M.","family":"Verbruggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lambin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9213-5126","authenticated-orcid":false,"given":"Guy M.","family":"Bormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.10.027_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2013.10.027_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0167-8140(03)00011-2","article-title":"Tumor hypoxia at the microregional level: clinical and predictive value of exogenous and endogenous hypoxic cell markers","volume":"10","author":"Bussink","year":"2003","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2013.10.027_bib3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/ijc.22436","article-title":"HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome","volume":"120","author":"Trastour","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2013.10.027_bib4","first-page":"68S","article-title":"PET-based treatment planning in radiotherapy: a new standard?","volume":"48","author":"Gregoire","year":"2007","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2013.10.027_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"6","author":"Brown","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2013.10.027_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semcancer.2010.02.003","article-title":"Cancer stem cells at the crossroads of current cancer therapy failures-radiation oncology perspective","volume":"2","author":"Koch","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2013.10.027_bib7","series-title":"Carbonic Anhydrase: Its Inhibitors and Activators","first-page":"255","article-title":"Cancer, related carbonic anhydrase isozymes and their inhibition","author":"Pastorekov\u00e1","year":"2004"},{"key":"10.1016\/j.ejmech.2013.10.027_bib8","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2013.10.027_bib9","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2013.10.027_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbapap.2009.07.027","article-title":"Biochemical and crystallographic characterization of a novel antitumor target","volume":"1804","author":"De Simone","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2013.10.027_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2013.10.027_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2013.10.027_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2008.07644.x","article-title":"Cancer-associated, hypoxia-inducible carbonic anhydrase IX facilitates CO2 diffusion","volume":"101","author":"Swietach","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.ejmech.2013.10.027_bib14","first-page":"1549","article-title":"A\u00a0carbonic anhydrase inhibitor as a potential modulator of cancer therapies","volume":"13","author":"Teicher","year":"1993","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2013.10.027_bib15","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1158\/1078-0432.CCR-04-2019","article-title":"Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer","volume":"11","author":"Atkins","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2013.10.027_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/01.sla.0000201452.09591.f3","article-title":"Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas","volume":"243","author":"Driessen","year":"2006","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ejmech.2013.10.027_bib17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1470-2045(07)70044-X","article-title":"Preoperative characterisation of clear-cell renal carcinoma using iodine-124 labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial","volume":"8","author":"Divgi","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2013.10.027_bib18","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1021\/jm031079w","article-title":"Carbonic anhydrase Inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX","volume":"47","author":"Casey","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.027_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.radonc.2011.05.045","article-title":"Specific inhibition of carbonic anhydrase IX activity enhances the in\u00a0vivo therapeutic effect of tumor irradiation","volume":"99","author":"Dubois","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2013.10.027_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.nucmedbio.2010.02.006","article-title":"Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in\u00a0vivo visualization of carbonic anhydrase IX expression in tumor hypoxia","volume":"5","author":"Akurathi","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2013.10.027_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14756360802218441","article-title":"Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines","author":"Morsy","year":"2009","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.027_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/jm3015348","article-title":"Synthesis and SAR of novel Re\/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia","volume":"56","author":"Lu","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.10.027_bib23","series-title":"Leachables and Extractables","first-page":"857","article-title":"Formulation and process development strategies for manufacturing biopharmaceuticals","author":"Jameel","year":"2010"},{"key":"10.1016\/j.ejmech.2013.10.027_bib24","first-page":"1198","article-title":"Evaluation of technetium-99m-triamide-mercaptide complexes designed to identify properties favoring renal tubular transport","volume":"35","author":"Hansen","year":"1994","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2013.10.027_bib25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00007691-199910000-00014","article-title":"Therapeutic monitoring of topiramate: evaluation of the saturable distribution between erythrocytes and plasma of whole blood using an optimized high-pressure liquid chromatography method","volume":"5","author":"Gidal","year":"1999","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejmech.2013.10.027_bib26","first-page":"177","article-title":"Molecular imaging I","volume":"vols. 185\/1, II","author":"Anthoni","year":"2008"},{"key":"10.1016\/j.ejmech.2013.10.027_bib27","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.bmcl.2007.09.055","article-title":"Synthesis and evaluation of a (99m)Tc-BAT-phenylbenzothiazole conjugate as a potential in\u00a0vivo tracer for visualization of amyloid beta","volume":"17","author":"Serdons","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.10.027_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0020-1693(00)83066-2","article-title":"Synthesis and characterization of monooxorhenium(V) complexes of mercaptoacetylglycylglycylglycine. Crystal structure of tetrabutylammonium oxo(mercaptoacetylglycylglycylglycine)rhenate(V)","volume":"180","author":"Rao","year":"1991","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ejmech.2013.10.027_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/(SICI)1099-1344(199908)42:8<737::AID-JLCR233>3.0.CO;2-Y","article-title":"Comparative evaluation of 99mTc-MAG2-ologodeoxynucleotides with phosphodiester and phosphorothioate backbones: preparation; stability and biodistribution","volume":"42","author":"Hjelstuen","year":"1999","journal-title":"J.\u00a0Labelled Compd. Radiopharm."},{"key":"10.1016\/j.ejmech.2013.10.027_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10967-007-0702-3","article-title":"Synthesis and biodistribution of 99mTc-peptides conjugated adenine as tumor imaging agents","volume":"273","author":"Zhao","year":"2007","journal-title":"J.\u00a0Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ejmech.2013.10.027_bib31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jlcr.1012","article-title":"Preparation, characterization and biological evaluation of 99mTc(CO)3-labelled cyclic polyamines","volume":"48","author":"Vanbilloen","year":"2005","journal-title":"J.\u00a0Labelled Compd. Radiopharm."},{"key":"10.1016\/j.ejmech.2013.10.027_bib32","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydratation activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.10.027_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0883-2897(92)90123-G","article-title":"Evaluation of 99mTc-mercaptoacetyltripeptides in mice and a baboon","volume":"3","author":"Bormans","year":"1992","journal-title":"Int. J. Radiat. Appl. Instrum. B"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413006685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413006685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T02:02:03Z","timestamp":1646964123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413006685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":33,"alternative-id":["S0223523413006685"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.10.027","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and biological evaluation of 99mTc-sulfonamide derivatives for in\u00a0vivo visualization of CA IX as surrogate tumor hypoxia markers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}